Century Therapeutics (IPSC) Non-Current Debt (2020 - 2022)
Century Therapeutics' (IPSC) quarterly Non-Current Debt came in at $3.7 million in Q4 2022, down 58.0% year-on-year from $8.9 million in Q4 2021, and down 39.06% on a QoQ basis from $6.1 million in Q3 2022.
Century Therapeutics (IPSC) Non-Current Debt (2020 - 2022) Analysis & Trends
Century Therapeutics (IPSC) has 3 years of Non-Current Debt data on file, last reported at $3.7 million in Q4 2022.
- On a quarterly basis, Non-Current Debt fell 58.0% year-over-year to $3.7 million in Q4 2022; TTM through Dec 2022 was $3.7 million, a 58.0% decrease from a year earlier, with the FY2022 full-year figure at $3.7 million, down 58.0% from the prior year.
- Non-Current Debt for Q4 2022 stood at $3.7 million, down from $6.1 million in the prior quarter.
- Over the last five years, Non-Current Debt for IPSC reached as high as $10.0 million in Q1 2022 and fell as low as $3.7 million in Q4 2022.
- Historically, Non-Current Debt has averaged $7.8 million across 3 years, with a median of $8.7 million in 2021.
- Across the five-year window, Non-Current Debt decreased 7.61% in 2021 and tumbled 58.0% in 2022, its largest moves.
- Year by year, Non-Current Debt stood at $9.6 million in 2020, then slipped by 7.61% to $8.9 million in 2021, then tumbled by 58.0% to $3.7 million in 2022.
- Per Business Quant data, the three most recent Non-Current Debt figures were $3.7 million in Q4 2022, $6.1 million in Q3 2022, and $8.5 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Century Therapeutics | 419.84 Mn | 285.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3.74 Mn |
| Sep 30, 2022 | 6.14 Mn |
| Jun 30, 2022 | 8.50 Mn |
| Mar 31, 2022 | 10.02 Mn |
| Dec 31, 2021 | 8.90 Mn |
| Dec 31, 2020 | 9.64 Mn |